USANA Accounts Payable vs Cash Analysis
USNA Stock | USD 39.90 0.54 1.37% |
USANA Health financial indicator trend analysis is much more than just breaking down USANA Health Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether USANA Health Sciences is a good investment. Please check the relationship between USANA Health Accounts Payable and its Cash accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Accounts Payable vs Cash
Accounts Payable vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of USANA Health Sciences Accounts Payable account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between USANA Health's Accounts Payable and Cash is 0.68. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of USANA Health Sciences, assuming nothing else is changed. The correlation between historical values of USANA Health's Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of USANA Health Sciences are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., USANA Health's Accounts Payable and Cash go up and down completely randomly.
Correlation Coefficient | 0.68 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents USANA Health obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of USANA Health Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Cash
Cash refers to the most liquid asset of USANA Health Sciences, which is listed under current asset account on USANA Health Sciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from USANA Health customers. The amounts must be unrestricted with restricted cash listed in a different USANA Health account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from USANA Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into USANA Health Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, USANA Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.36, whereas Selling General Administrative is forecasted to decline to about 220.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 968.6M | 804.7M | 744.3M | 475.7M | Total Revenue | 1.2B | 998.6M | 921.0M | 585.9M |
USANA Health fundamental ratios Correlations
Click cells to compare fundamentals
USANA Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
USANA Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 22.8M | 21.3M | 20.3M | 19.3M | 19.3M | 27.4M | |
Total Assets | 516.9M | 640.9M | 577.7M | 596.5M | 632.8M | 664.4M | |
Other Current Liab | 101.4M | 105.0M | 104.0M | 88.8M | 83.5M | 57.3M | |
Total Current Liabilities | 136.1M | 168.1M | 160.8M | 143.8M | 118.8M | 76.4M | |
Total Stockholder Equity | 351.7M | 441.7M | 395.1M | 434.5M | 497.2M | 522.1M | |
Property Plant And Equipment Net | 95.2M | 100.4M | 101.8M | 97.8M | 99.8M | 60.0M | |
Net Debt | (226.5M) | (303.3M) | (232.8M) | (281.5M) | (317.2M) | (301.4M) | |
Retained Earnings | 306.1M | 382.8M | 344.6M | 391.6M | 445.2M | 467.5M | |
Accounts Payable | 12.5M | 18.2M | 13.5M | 11.0M | 10.1M | 8.2M | |
Cash | 234.8M | 311.9M | 239.8M | 288.4M | 330.4M | 346.9M | |
Non Current Assets Total | 187.7M | 215.6M | 212.6M | 212.2M | 215.0M | 110.8M | |
Non Currrent Assets Other | 40.0M | 59.3M | 34.1M | 51.9M | 54.9M | 57.6M | |
Cash And Short Term Investments | 234.8M | 311.9M | 239.8M | 288.4M | 330.4M | 346.9M | |
Liabilities And Stockholders Equity | 516.9M | 640.9M | 577.7M | 596.5M | 632.8M | 664.4M | |
Inventory | 68.9M | 90.2M | 98.3M | 67.1M | 61.5M | 40.7M | |
Other Current Assets | 25.5M | 15.7M | 19.8M | 21.7M | 18.7M | 16.4M | |
Other Stockholder Equity | 59.4M | 62.5M | 50.0M | 55.6M | 65.7M | 36.1M | |
Total Liab | 165.2M | 199.2M | 182.6M | 162.1M | 135.6M | 88.4M | |
Property Plant And Equipment Gross | 126.5M | 100.4M | 101.8M | 222.5M | 228.8M | 240.2M | |
Total Current Assets | 329.3M | 425.3M | 365.1M | 384.4M | 417.7M | 438.6M | |
Accumulated Other Comprehensive Income | (13.9M) | (3.6M) | 458K | (12.8M) | (13.7M) | (13.0M) | |
Current Deferred Revenue | 13.9M | 16.0M | 19.6M | 20.9M | 13.9M | 12.0M | |
Net Receivables | 8.8M | 7.4M | 7.2M | 7.2M | 7.2M | 7.0M | |
Non Current Liabilities Total | 29.1M | 31.2M | 21.8M | 18.2M | 16.7M | 12.9M | |
Short Term Debt | 8.3M | 8.6M | 7.1M | 6.9M | 8.1M | 11.9M | |
Other Assets | 26.2M | 67.0M | 62.7M | 50.7M | 1.0 | 0.95 | |
Property Plant Equipment | 95.2M | 100.4M | 101.8M | 111.7M | 128.4M | 68.0M | |
Other Liab | 11.9M | 12.0M | 21.8M | 10.6M | 12.1M | 7.1M | |
Good Will | 16.6M | 17.4M | 17.7M | 17.4M | 17.1M | 14.8M | |
Intangible Assets | 29.8M | 30.8M | 30.4M | 32.4M | 29.9M | 28.3M | |
Net Tangible Assets | 305.2M | 441.7M | 347.0M | 384.7M | 442.4M | 297.1M | |
Retained Earnings Total Equity | 329.5M | 306.1M | 382.8M | 344.6M | 396.3M | 258.5M | |
Capital Surpluse | 72.0M | 59.4M | 62.5M | 50.0M | 57.5M | 67.0M | |
Deferred Long Term Liab | 13.4M | 10.3M | 12.0M | 7.5M | 8.6M | 10.3M | |
Non Current Liabilities Other | 18.8M | 19.2M | 14.3M | 14.2M | 12.2M | 7.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.